BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Autoimmunity
,
Fenofibrate
,
rs2230926
,
PTEN
,
calcium channel activity
,
Hepatitis
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
SCH23390
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
No genes found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
No biogroups found
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
No studies found
Explore Curated Studies Results
Literature
Most Relevant Literature
SCH23390 and a humanized anti-cocaine mAb decrease the latency to cocaine-induced reinstatement of l…
The dopamine D1 receptor antagonist SCH-23390 blocks the acquisition, but not expression of mitragyn…
SCH 23390 inhibits the acquisition of nitrous oxide-induced conditioned place preference and the cha…
SCH23390 Reduces Methamphetamine Self-Administration and Prevents Methamphetamine-Induced Striatal L…
Examination of the effects of SCH23390 and raclopride infused in the dorsal striatum on amphetamine-…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Investigations of the Pathophysiology of Gilles de la Tourette Syndrome. Part 1: Simultaneous PET an…
Blinking and Yawning in Epilepsy: The Role of Dopamine
A Study To Evaluate D1 Receptor Occupancy (RO) Following Single Dose of PF-06412562 In Healthy Male …
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ